SCHEMBL20426249

SCHEMBL20426249

c1ccc(-n2c3ccccc3c3c4c(ccc32)ccn4-c2cnc(-c3cccnc3)nc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ CLK4 Q9HAZ1 3/20 0.36
▸ USP2 O75604 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ GBA1 P04062 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ CYP2D6 P10635 3/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CYP2A6 P11509 1/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20426229 0.92 L3MBTL1 (0.39) MEN1KMT2ALMNACYP2C19HTT
SCHEMBL20426251 0.90 KDM4E (0.35) CYP3A4MEN1CYP1A2KMT2AUSP2
SCHEMBL20426207 0.87 CYP2A6 (0.38) CYP3A4MEN1CYP1A2KMT2ACLK4
SCHEMBL16357539 0.87 KDM4E (0.36) KMT2ALMNANPC1RAB9AL3MBTL1
SCHEMBL20426233 0.87 MAPT (0.36) MEN1KMT2ACYP11B2L3MBTL1KDM4E
SCHEMBL20426159 0.87 CYP3A4 (0.39) CYP3A4MEN1CYP1A2KMT2ACLK4
SCHEMBL16357513 0.85 DYRK1A (0.36) CYP3A4MEN1CYP1A2KMT2AUSP2
SCHEMBL16357470 0.84 MAPT (0.36) CYP11B2L3MBTL1ALDH1A1MAPT
SCHEMBL20426230 0.83 COMT (0.37) CYP11B2MAPT
SCHEMBL16357416 0.83 CYP2A6 (0.38) CYP3A4MEN1CYP1A2KMT2ACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU CYP3A4 387/4885MEN1 2218/4885CYP1A2 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback